The viability of fat grafts harvested with an established technique after cryopreservation remains unknown. This study was conducted in vitro to evaluate the viability of autologous fat grafts harvested with the Coleman technique and subsequently preserved with our preferred cryopreservation method. Eight adult females were enrolled in this study. In each patient, 10 mL of fat grafts were harvested with the Coleman technique by a single surgeon from the lower abdomen. In group 1, 5 mL of fresh fat grafts were mixed with cryoprotective agents and underwent cryopreservation with controlled slow cooling and fast rewarming. In group 2, 5 mL of fresh fat grafts without cryopreservation from the same patient served as a control. The fat graft samples from both groups were evaluated with trypan blue vital staining, glycerol-3-phophatase dehydrogenase assay, and routine histology. Viable adipocyte counts were found similar in both group 1 and group 2 (3.46 Ϯ 0.91 vs. 4.12 Ϯ 1.11 ϫ 10 6 /mL, P ϭ 0.22). However, glycerol-3-phophatase dehydrogenase activity was significantly lower in group 1 compared with group 2 (0.47 Ϯ 0.09 vs. 0.66 Ϯ 0.09 u/mL, P Ͻ 0.001). Histologically, the normal structure of fragmented fatty tissues was found primarily in both groups. Our results indicate that autologous fat grafts harvested with the Coleman technique and preserved with our preferred cryopreservation method have a normal histology with near the same number of viable adipocytes as compared with the fresh fat grafts. However, those cryopreserved fat grafts appear to have a less optimal level of adipocyte specific enzyme activity compared with the fresh ones and thus may not survive well after they are transplanted without being optimized.
A utologous fat grafting has been considered as a valid option of choice by many surgeons for soft tissue augmentation in both cosmetic and reconstructive surgery since the procedure was refined and popularized by Coleman a decade ago. 1 So far, structural fat grafting has been used successfully for facial or hand rejuvenation, [2] [3] [4] body contouring, 5, 6 buttock or breast augmentation. [7] [8] [9] [10] However, one of the main obstacles to achieve long-term favorable results of soft tissue augmentation after autologous fat grafting is the variable rate of absorption in the grafted site, which may be 50% or more of the filled volume. [11] [12] [13] The high rate of absorption after fat grafting often necessitates either overcorrection or repeated procedures in the desired area, resulting in less optimal appearance, patient dissatisfaction, and/or more procedures with increased cost, and morbidity, and repeated trauma of the donor site.
At the present time, fat grafts can primarily be used for immediate grafting during the same setting of fat-graft harvesting. Excess fat grafts obtained from the procedure are unfortunately discarded after the initial fat grafting. It has been a strong desire of both plastic surgeons and patients to be able to preserve these for potential future applications if a reliable technique can be developed for long-term preservation of fat grafts. There have been ongoing interests by number of investigators to develop a better technique for long-term preservation of fat grafts for possible repeated fat grafting. 14 -19 Although a few recent studies discuss the possibility of long-term preservation of fat grafts, 14 -19 the viability of autologous fat grafts harvested with an established technique and preserved with a cryopreservation method developed in our laboratory remains unknown. The present study was, therefore, conducted to evaluate the viability of autologous fat grafts harvested and refined with the Coleman technique using a syringe, cannula, and centrifuge and subsequently preserved with our established method for cryopreservation of adipose tissues.
MATERIALS AND METHODS

Fat Graft Harvesting
Eight adult white females (ages: 23-57 years) who had no major systemic metabolic diseases or lipid disorders were enrolled in this study and the study was approved by the University's Institutional Review Board. In each patient, 10 mL of fat grafts were harvested with the Coleman technique by a single surgeon (S.R.C.) from the abdomen according to his well described and established method. [1] [2] [3] Briefly, through a small incision, a mixed solution (0.5% lidocaine with 1:200,000 of epinephrine in Lactated Ringer's solution) was infiltrated into the lower abdominal donor site using a blunt Lamis infiltrator (Byron Medical Inc., Tucson, AZ). The solutions were infiltrated in a ratio of 1 mL of solution per cubic centimeter of fat grafts to be harvested. The fat grafts were harvested through the same incisions made previously. The harvesting cannula was 3 mm in diameter and 15 or 23 cm in length with a blunt tip (Byron Medical Inc., Tucson, AZ). It was connected to a 10 mL Luer-Lok syringe. Gently pulling back on the plunger of a 10 mL syringe provided a light-negative pressure while the cannula was advanced and retracted through the harvested site. After filling the syringe with harvested tissue, the cannula was removed from the syringe. A Luer-Lok plug was twisted onto the syringe to seal the Luer-Lok aperture and the plunger was removed from the barrel of the syringe and the body of the filled syringe was placed into a centrifuge (Byron Medical Inc., Tucson, AZ) and spun at 3000 rpm for 3 minutes. After centrifugation, the oil layer (upper level) was decanted and the aqueous layer (lower level) was drained out of the syringe. The middle layer, composed of predominantly fat grafts, was used for the present study.
Procedure of Cryopreservation
Selection of Cryoprotective Agents
In this study, dimethyl sulfoxide (DMSO), a permeable cryoprotective agent (CPA) that could reduce cell injury due to the intracellular ice formation and "solution effects," and trehalose, a nonpermeable CPA that could protect the cell membrane, were selected. 20, 21 This optimal combination, consisting of 0.5 M (3.3%) DMSO (Sigma, St. Louis, MO) and 0.2 M (7.6%) trehalose (Sigma, St. Louis, MO), was used in this study according to our previous studies.
14,15
Freezing and Thawing and Experimental Protocol
The freezing and thawing methods used in this study were reported previously. 14, 15 In group 1 (N ϭ 8), 1 mL of fat grafts was put into a 3 mL vial and mixed with 1 mL of a combined DMSO (in 0.5 M) and trehalose (in 0.2 M) solution. After adding CPAs, the vial was placed in room temperature for 10 minutes and then put into a methanol bath (Kinetics, Stone Ridge, NY). The freezing system was set up at 1°C-2°C per minute of slow cooling rate from 22°C to Ϫ30°C without artificial induced ice formation. The vial was then transferred into liquid nitrogen at Ϫ196°C. After it reached Ϫ30°C, it was held there for 10 minutes for long-term preservation. The cryopreserved fat grafts, once they became stabilized in liquid nitrogen for about 20 minutes, were considered to be equivalent to the condition after long-term preservation and were ready for thawing. This is because once fat grafts are frozen in liquid nitrogen at Ϫ196°C, the living cells within the fat grafts are simply "sleeping" with little metabolism and structural changes and thus can be stored as long as they are needed. In general, all potential injuries to the living cells within the cryopreserved tissue occur primarily during both freezing and thawing processes. The duration in term of how long the tissue is stored once it becomes stabilized in liquid nitrogen at Ϫ196°C has little impact on the tissue regarding its viablity. 20 Before thawing, the vial containing cryopreserved fat grafts was taken from the liquid nitrogen tank and placed in room temperature for 2 minutes. The vial was then placed into a stirred 37°C water bath until the preserved adipose aspirates were thoroughly thawed within 5 minutes. The cryopreserved fat grafts after thawing were then evaluated accordingly.
In group 2 (N ϭ 8), 1 mL of fat grafts from the same patient without undergoing cryopreservation was then mixed with 1 mL of normal saline and placed in room temperature served as a control.
Evaluation of Cryopreserved or Fresh Fat Grafts
Viable Adipocyte Count
One gram of cryopreserved fat graft specimen from each patient of group 1 and one gram of fresh fat graft specimen from each patient of group 2 were collected. Each specimen was washed 3 times with phosphate-buffered solution (PBS). It was then mixed with 1 mg per mL of type I collagenase (Sigma, St. Louis, MO) in PBS containing 5% bovine serum albumin (Sigma, St. Louis, MO) for digestion and was incubated at 37°C in a CO 2 incubator. After 1 hour incubation, the digestion was terminated with 10% (vol/vol) fetal calf serum (Sigma, St. Louis, MO) and any remaining tissue fragments were removed by straining the digested fatty tissues through a piece of large weave gauze. The digested fat grafts were fractionated into mature adipocytes (top layer) and stromal pellet (bottom) after a centrifugation at 200g for 10 minutes. The viable adipocytes were determined after 0.4% trypan blue vital stain (Sigma, St. Louis, MO) from a 100 L sample with 1:1 dilution with trypan blue. The number of viable adipocytes was then counted with a hemocytometer under a microscope with ϫ400 magnification.
Glycerol-3-Phosphate Dehydrogenase (G3PDH) Assay
G3PDH assay was chosen in our study to assess cellular function of adipose tissue because it is relatively simple and the enzyme is adipose-specific. The assay measures the level of G3PDH within the cytoplasm of adipocytes. The higher level of the enzyme represents a better cellular function of adipose tissue. 22 According to the instruction from the manufacture (Kamiya Biomedical Co., Seattle, WA), G3PDH activity within fat grafts was evaluated using a spectrophotometric assay. Briefly, 1 gram of cryopreserved fat graft specimen from group 1 and 1 gram of fresh fat graft specimen from group 2 from each patient were collected. Each cryopreserved or fresh fat graft specimen was mixed with 4 mL of 0.25 molar cane sugar solutions and homogenized. The mixture was then spun at 700g at 4°C for 10 minutes and the supernatant was taken to the special centrifuge tube, which was again spun but at 54,000g for 60 minutes. The supernatant obtained after the second centrifugation was diluted approximately 20 to 100 times with an enzyme extracting reagent. Final procedures of the assay were as follows: the substrate reagent (400 L) was dispensed into an assay well and heated to 25°C; the diluted supernatant was also heated to 25°C and 200 L of it added to the well and mixed with the substrate reagent; the optical absorption at 340 nm was measured for 3 to 10 minutes and plotted on a graph; the change in optical density (⌬ OD) per minute from the linear position of the curve was obtained; and G3PDH activity was calculated based on the formula (G3PDH activity (U/mL) ϭ ⌬ OD at 340 nm/min ϫ0.482) and the value expressed as U/mL.
Histology
Either cryopreserved or fresh fat graft specimen (about 3 g) was fixed immediately in 10% buffered formalin, concentrated by gravity filtration through a porous paper, processed through graded alcohols and xylene, embedded in paraffin, sectioned at 5 m in thickness, and stained with hematoxylin and eosin (H and E) staining. All histologic slides were examined by an experienced pathologist in a single-blinded fashion for architectural disruption, adipocyte degeneration or necrosis.
Statistical Analysis
All data in this study were expressed as mean Ϯ standard deviation (mean Ϯ SD). A 2-tailed paired Student t test was used to assess the difference between the 2 groups. A P-value less than 0.05 was considered statistically significant.
RESULTS
In this study, the total number of viable adipocytes in group 1 was 3.46 Ϯ 0.91 ϫ 10 6 /mL and in group 2 was 4.12 Ϯ 1.11 ϫ 10 6 /mL. Although slightly lower viable adipocyte count was found in group 1 compared with group 2, the difference of viable adipocyte counts between the 2 groups was not statistically significant (P ϭ 0.22) (Fig. 1) .
G3PDH assay was used in this study to assess cellular function of fat grafts in each group. The higher the enzyme activity level was, the better cellular function of adipocytes within fat grafts was. The G3PDH activity in group 1 was 0.47 Ϯ 0.09 u/mL and in group 2 was 0.66 Ϯ 0.09 u/mL. The lower level of the enzyme activity was found in group 1 compared with group 2. The difference of G3PDH activity between both groups was statistically significant (P Ͻ 0.001) (Fig. 2) .
No evidence of fatty tissue degeneration or necrosis was found in either group. Normal structure of fragment fatty tissues was found primarily and the basic structure of fragmental fatty tissues was well maintained in group 1. No distinguishable differences were seen histologically in group 1 (Fig. 3A ) compared with group 2 (Fig. 3B) .
DISCUSSION
Studies of fat viability after long-term preservation have conflicted with each another. One previous study clearly indicated that storage of fat grafts in a refrigerator resulted in significant decrease of viable adipocytes within adipose tissues. 23 A simple freezing with liquid nitrogen had also been used by a number of investigators to explore the possibility of long-term storage of fat grafts. In one study, fat grafts were frozen in liquid nitrogen and FIGURE 1. Viable adipocytes from the cryopreserved fat grafts were stained with 0.4% trypan blue and were found as "intact" cells under microscope. (Original magnification ϫ100).
FIGURE 2.
An example of 4 fat graft samples from the cryopreserved group was evaluated for their glycerol-3-phosphate dehydrogenase activities. The degree of the slope represented the activity of each fat graft sample that was calculated based on the formula.
FIGURE 3.
Histologic examination (hematoxylin and eosin staining, original magnification ϫ100) demonstrated that the cryopreserved fat grafts were able to maintain essentially the normal structure of fragmented fatty tissues. There were no obvious differences between the cryopreserved (A) and fresh (B) fat grafts harvested with the Coleman technique.
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Cryopreservation of Autologous Fat Grafts stored at Ϫ195.8°C for up to 8 days. The results demonstrated that the frozen fat grafts showed remarkable maintenance of mitochondrial metabolic activity. 16 However, a separate study by others indicated that after simple freezing, up to 92.7% of metabolic activity of fat grafts was lost, but the addition of a CPA led to preservation of up to 54% of the baseline activity. The authors concluded that the widely used practice of simple freezing in a freezer leads to nonviable tissue and cell survival, and the addition of a CPA was necessary to improve viability of cryopreserved fat grafts. 18 In another study, fat grafts were simply frozen in liquid nitrogen and stored at Ϫ35°C for 6 months. Interestingly, the authors found that the viability and histology of fat grafts frozen in liquid nitrogen were similar to those of fresh grafts. 19 However, their finding has been questioned by other investigators who have found that to achieve optimal cryopreservation of adipose tissues, it would be necessary to add a CPA before freezing and fat grafts mixed with a CPA should also undergo controlled freezing and thawing during cryopreservation. 14, 15, 17, 18, 24 The modern technique of cryopreservation permits the longterm storage of living cells and tissues that may have many potential clinical applications. The major steps of cryopreservation process can be summarized as follows: (1) add CPAs to cells/tissues before cooling, (2) cool the cells/tissues in a controlled rate toward a low temperature at which the cells/tissues are stored, (3) warm the cells/tissues, and (4) remove the CPAs from the cells/tissues after thawing. 20 The optimal cooling rate for cell survival should be slow enough to avoid intracellular ice formation but fast enough to minimize the cell damage. The freezing behavior of the cells can also be modified by the addition of CPAs, which affect the rates of water transport, nucleation, and crystal growth. Cells that have survived cooling still face the challenges of thawing which can exert effects on survival comparable to those of the rate of cooling. Also, knowledge of the cell permeability to water and CPAs allows one to predict minimal and maximal cell volume excursion during the addition and removal of CPAs in the cells to provide a quantitatively optimal approach toward avoiding osmotic damage. 20, 21 DMSO, a permeable agent, has been widely used as an effective CPA in cryopreservation of living cells or tissues. 20, 21 Because this agent is tissue toxic at normal body temperature, it should be removed from the previously cryopreserved cells or tissues after thawing. 21 In our previous study, we attempted to lower the concentration of DMSO used in cryopreservation of adipose tissues by adding another nontissue toxic CPA, such as trehalose. 14, 15 As a CPA, trehalose can dehydrate cells and thus reduce the amount of water present before freezing. It also can stabilize cellular membranes and proteins during freezing and drying. A combination of trehalose, a nonpermeable CPA, with DMSO, a permeable CPA, may significantly enhance the protective effect of adipose tissue during cryopreservation through a possible synergistic mechanism but the detail mechanism still remains uncertain. 25 Therefore, the concentration of DMSO can be theoretically reduced when it is used in combination with trehalose. The combined use of both DMSO and trehalose as CPAs along with our recent developed cooling and freezing protocol may be valuable to achieve optimal cryopreservation of adipose tissue.
In this study, autologous fat grafts harvested with the Coleman technique were preserved by means of our preferred cryopreservation method with a combination of DMSO and trehalose as CPAs and a specific cooling and warming protocol for adipose tissue. The method used in this study was specifically developed for adipose tissue and has been proven to provide optimal cryopreservation of adipose aspirates. 14, 15 Since the Coleman technique is an established method for fat graft harvesting by most surgeons, 13 it would be helpful to determine the viability of the cryopreserved fat grafts harvested with this frequently used technique. In this way, the variations of harvesting techniques can be minimized and the findings of the study can potentially be more meaningful to predict the outcome of autologous fat grafts preserved with our preferred cryopreservation method for future repeated fat grafting. The results from this study clearly demonstrate that the cryopreserved fat grafts harvested with the Coleman technique and preserved with our preferred cryopreservation method have a normal histology with near the same number of viable adipocytes as compared with the fresh fat grafts harvested with the same technique by the same surgeon based on the viable adipocyte counts. However, the cryopreserved fat grafts appear to have a less optimal level of adipocyte specific enzyme activity compared with the fresh ones evaluated by the G3PDH assay. Therefore, the cryopreserved fat grafts harvested with an established technique and preserved with our preferred method may not survive well as fresh ones if they are used for future repeated fat grafting. Future in vivo study will be conducted to confirm this finding. The cryopreservation method used in this study and developed specifically for adipose tissue appears to provide good longterm preservation of fat grafts. However, the overall quality of the cryopreserved fat grafts is still less ideal than the fresh ones. This is true not only for adipose tissue but also for other types of tissues after an "optimal" cryopreservation. 20, 21 In addition, the sample size of the present study is relatively small and the findings from the study may need to be confirmed by future study with more patient enrollment. Refinements may still be needed to improve the techniques used for cryopreservation of adipose tissue to achieve the best possible viability of fat grafts after cryopreservation. For example, a specific CPA or a different combination of available CPAs probably exists that would provide better protection of adipose tissue during cryopreservation. We are currently investigating a more reliable but clinically feasible method that can be used for successful long-term preservation of adipose tissue. Several methods have been described to optimize fat grafts before they are transplanted in vivo for possible augmentation of fat graft survival. For example, pretreatment of fat grafts with cell culture medium or growth factors may increase survival of fat grafts in the recipient sites. 26 -29 If the cryopreserved fat grafts harvested with the Coleman technique can be pretreated with cell culture medium or growth factors after rewarming, those fat grafts may resume their optimal intracellular enzyme activities and thus can be potentially used as fresh fat grafts for future clinical applications of fat grafting. Those cryopreserved fat grafts may also be optimized with the current tissue engineering techniques for more purified viable adipocytes within fat grafts after rewarming and thus may improve overall survival after they are transplanted in vivo. 30, 31 All above techniques represent other ways to potentially improve viability of the cryopreserved fat grafts before they can be used for future fat grafting. Recently, cell-assisted lipotransfer has been introduced with promising preliminary results. 32, 33 If this technology can safely be used in a clinical setting, the cryopreserved fat grafts after rewarming may also be pretreated with patient's own cryopreserved adipose-derived stem cells to promote fat graft taken. 34, 35 In conclusion, the present study is the first preliminary report on cryopreservation of autologous fat grafts harvested with the Coleman technique. Our results indicate that autologous fat grafts harvested with the Coleman technique and then preserved with our preferred cryopreservation method have a normal histology with near the same number of viable adipocytes as compared with the fresh fat grafts. However, these cryopreserved fat grafts appear to have a less optimal level of adipocyte specific enzyme activity compared with the fresh ones. Although the cryopreserved fat grafts may not survive well as the fresh ones after they are transplanted in
